Brian Glazer

Title: Brian Glazer: Innovator in Systematic Delivery of SSRIs

Introduction

Brian Glazer is an accomplished inventor based in Franklin Township, NJ (US). He has made significant contributions to the field of pharmacology, particularly in the delivery of serotonin reuptake inhibitors (SSRIs). His innovative approach aims to enhance the treatment of various mental health conditions.

Latest Patents

Brian Glazer holds a patent for a method of systematically delivering SSRIs. This patent outlines methods and compositions for the intravaginal or rectal delivery of selected SSRIs to the systemic circulation. Such methods are particularly useful in treating depression, migraine headaches, chronic pain, psychoactive substance abuse disorders, pre-menstrual dysphoric disorder (PMDD), and obsessive-compulsive disorders. The compositions can be formulated for immediate release or controlled release of SSRIs over an extended period. A preferred SSRI mentioned in his patent is fluoxetine.

Career Highlights

Brian Glazer is currently associated with Duramed Pharmaceuticals, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in drug delivery systems has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Brian has collaborated with notable colleagues, including Anu Mahashabde and Martha Francine Kay. These collaborations have further enriched his work and contributed to advancements in pharmaceutical research.

Conclusion

Brian Glazer's innovative work in the systematic delivery of SSRIs showcases his commitment to improving treatment options for mental health disorders. His contributions to the field are significant and continue to impact the lives of many individuals.